Skip to main content

Long-Term Effects of Achlorhydria on the Stomach (Helicobacter pylori and PPI Therapy)

  • Chapter
  • First Online:
Esophageal and Gastric Disorders in Infancy and Childhood

Abstract

Review of the physiology of acid secretion and main consequences of reduced secretion of gastric acid. Short- and long-term effects both from pathology and medically induced hypochlorhydria are discussed.

There are considerable implications derived from modification of the normal gastric acidity, namely, infectious, nutritional and immunological.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Giannella RA, Broitman SA, Zamcheck N. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med. 1973;78:271–6.

    Google Scholar 

  2. Giannella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut. 1972;13:251–6.

    Google Scholar 

  3. Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987;28:96–107.

    Google Scholar 

  4. Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, Wirz A, Preston T, McColl KE. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000;119:339–47.

    Google Scholar 

  5. Mowat C, McColl KE. Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy. Best Pract Res Clin Gastroenterol. 2001;15:523–37.

    Google Scholar 

  6. Ramsey EJ, Carey KV, Peterson WL, Jackson JJ, Murphy FK, Read NW, Taylor KB, Trier JS, Fordtran JS. Epidemic gastritis with hypochlorhydria. Gastroenterology. 1979;76:1449–57.

    Google Scholar 

  7. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.

    Google Scholar 

  8. Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics. 2006;117:e396–404.

    Google Scholar 

  9. Sugimoto M, Furuta T, Yamaoka Y. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009;24:1725–32.

    Google Scholar 

  10. Sierra R, Une C, Ramirez V, De Mascarel A, Pizar-Alpizar W, Gonzalez MI, Ramirez JA, Cuenca P, Perez-Perez G, Megraud F. Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms. World J Gastroenterol. 2008;14:6481–7.

    Google Scholar 

  11. Putnam PE. Stop the PPI express: they don’t keep babies quiet! J Pediatr. 2009;154:475–6.

    Google Scholar 

  12. Bright GM, Blizzard RM, Kaiser DL, Clarke WL. Organ-specific autoantibodies in children with common endocrine diseases. J Pediatr. 1982;100:8–14.

    Google Scholar 

  13. Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann. 1980;9:154–62.

    Google Scholar 

  14. Segni M, Borrelli O, Pucarelli I, Delle FG, Pasquino AM, Annibale B. Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab. 2004;89:4944–8.

    Google Scholar 

  15. Greenwood DL, Crock P, Braye S, Davidson P, Sentry JW. Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability. Eur J Pediatr. 2008;167:917–25.

    Google Scholar 

  16. Venugopal B, Browning MF, Curcio-Morelli C, Varro A, Michaud N, Nanthakumar N, Walkley SU, Pickel J, Slaugenhaupt SA. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum Genet. 2007;81:1070–83.

    Google Scholar 

  17. Altarescu G, Sun M, Moore DF, Smith JA, Wiggs EA, Solomon BI, Patronas NJ, Frei KP, Gupta S, Kaneski CR, Quarrell OW, Slaugenhaupt SA, Goldin E, Schiffmann R. The neurogenetics of mucolipidosis type IV. Neurology. 2002;59:306–13.

    Google Scholar 

  18. Lubensky IA, Schiffmann R, Goldin E, Tsokos M. Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia. Am J Surg Pathol. 1999;23:1527–31.

    Google Scholar 

  19. Schiffmann R, Dwyer NK, Lubensky IA, Tsokos M, Sutliff VE, Latimer JS, Frei KP, Brady RO, Barton NW, Blanchette-Mackie EJ, Goldin E. Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia. Proc Natl Acad Sci U S A. 1998;95:1207–12.

    Google Scholar 

  20. Bourgois B, Boman F, Nelken B, Bonnevalle M, Turck D. Intractable diarrhoea revealing a neuroblastoma hypersecreting the vasoactive intestinal peptide. Arch Pediatr. 2004;11:340–3.

    Google Scholar 

  21. Kimura N, Yamamoto H, Okamoto H, Wakasa H, Nagura H. Multiple-hormone gene expression in ganglioneuroblastoma with watery diarrhea, hypokalemia, and achlorhydria syndrome. Cancer. 1993;71:2841–6.

    Google Scholar 

  22. Zhang WQ, Liu JF, Zhao J, Zhao SY, Xue Y. Tumor with watery diarrhoea, hypokalaemia in a 3-year-old girl. Eur J Pediatr. 2009;168:859–62.

    Google Scholar 

  23. Smith SS, Shulman DI, O’Dorisio TM, McClenathan DT, Borger JA, Bercu BB, Root AW. Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: effect of the long-acting somatostatin analogue SMS 201-995 on the disease and linear growth. J Pediatr Gastroenterol Nutr. 1987;6:710–6.

    Google Scholar 

  24. Euler AR, Lechago J, Byrne W, France GL. Transient hypergastrinemia of 2 years’ duration in a young pediatric patient. J Pediatr Gastroenterol Nutr. 1984;3:300–3.

    Google Scholar 

  25. Delle FG, Helander H, Holt S, Modlin IM, Powers R, Solcia E, Soll A, Tielemans Y, Wright NA. Acid suppression and gastric mucosal cell biology. Dig Dis Sci. 1994;39:1843–52.

    Google Scholar 

  26. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006.

    Google Scholar 

  27. Solcia E, Fiocca R, Villani L, Gianatti A, Cornaggia M, Chiaravalli A, Curzio M, Capella C. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol Suppl. 1991;180:146–59.

    Google Scholar 

  28. Solcia E, Fiocca R, Villani L, Luinetti O, Capella C. . Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. Am J Surg Pathol. 1995;19 Suppl 1:S1–7.

    Google Scholar 

  29. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2000;14:651–68.

    Google Scholar 

  30. Alonso FF, Codoceo AR, Polanco AI, Aguado GA, Fontan CG. Study of gastrointestinal polypeptides controlling gastric acid secretion in patients with primary antibody deficiency. Rev Esp Enferm Dig. 1999;91:47–60.

    Google Scholar 

  31. Conley ME, Ziegler MM, Borden S, Huff DS, Boyle JT. Multifocal adenocarcinoma of the stomach in a child with common variable immunodeficiency. J Pediatr Gastroenterol Nutr. 1988;7:456–60.

    Google Scholar 

  32. Dolby JM, Webster AD, Borriello SP, Barclay FE, Bartholomew BA, Hill MJ. Bacterial colonization and nitrite concentration in the achlorhydric stomachs of patients with primary hypogammaglobulinaemia or classical pernicious anaemia. Scand J Gastroenterol. 1984;19:105–10.

    Google Scholar 

  33. Salgueiro J, Zubillaga M, Goldman C, Barrado A, Martinez SM, Leonardi N, Boccio J. Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther. 2004;20:1029–34.

    Google Scholar 

  34. Dale A, Thomas JE, Darboe MK, Coward WA, Harding M, Weaver LT. Helicobacter pylori infection, gastric acid secretion, and infant growth. J Pediatr Gastroenterol Nutr. 1998;26:393–7.

    Google Scholar 

  35. Demir H, Saltik IN, Kocak N, Yuce A, Ozen H, Gurakan F. Subnormal growth in children with Helicobacter pylori infection. Arch Dis Child. 2001;84:89–90.

    Google Scholar 

  36. McCallion WA, Ardill JE, Bamford KB, Potts SR, Boston VE. Age dependent hypergastrinaemia in children with Helicobacter pylori gastritis–evidence of early acquisition of infection. Gut. 1995;37:35–8.

    Google Scholar 

  37. Park JH, Kim SY, Kim DW, Lee WG, Rhee KH, Youn HS. Correlation between Helicobacter pylori infection and vitamin C levels in whole blood, plasma, and gastric juice, and the pH of gastric juice in Korean children. J Pediatr Gastroenterol Nutr. 2003;37:53–62.

    Google Scholar 

  38. Weaver LT. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 16 February 1995. Aspects of Helicobacter pylori infection in the developing and developed world.Helicobacter pylori infection, nutrition and growth of West African infants. Trans R Soc Trop Med Hyg. 1995;89:347–50.

    Google Scholar 

  39. Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics. 2007;119:e754–9.

    Google Scholar 

  40. Barabino A, Dufour C, Marino CE, Claudiani F, De AA. Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence. J Pediatr Gastroenterol Nutr. 1999;28:116–9.

    Google Scholar 

  41. Baysoy G, Ertem D, Ademoglu E, Kotiloglu E, Keskin S, Pehlivanoglu E. Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2004;38:146–51.

    Google Scholar 

  42. Soylu OB, Ozturk Y. Helicobacter pylori infection: effect on malnutrition and growth failure in dyspeptic children. Eur J Pediatr. 2008;167:557–62.

    Google Scholar 

  43. Kostaki M, Fessatou S, Karpathios T. Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr. 2003;162:177–9.

    Google Scholar 

  44. Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle FG. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003;52:496–501.

    Google Scholar 

  45. Tang G, Serfaty-Lacrosniere C, Camilo ME, Russell RM. Gastric acidity influences the blood response to a beta-carotene dose in humans. Am J Clin Nutr. 1996;64:622–6.

    Google Scholar 

  46. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947–53.

    Google Scholar 

  47. Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008;179:319–26.

    Google Scholar 

  48. Canani RB, Terrin G. Gastric acidity inhibitors and the risk of intestinal infections. Curr Opin Gastroenterol. 2010;26:31–5.

    Google Scholar 

  49. Tennant SM, Hartland EL, Phumoonna T, Lyras D, Rood JI, Robins-Browne RM, van Driel IR. Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun. 2008;76:639–45.

    Google Scholar 

  50. Tamplin ML. Inactivation of Escherichia coli O157:H7 in simulated human gastric fluid. Appl Environ Microbiol. 2005;71:320–5.

    Google Scholar 

  51. Khatami SS, Mukunda B, Ravakhah K. Coinfection with Giardia lamblia and Clostridium difficile after use of ranitidine. Am J Med Sci. 2004;327:91–3.

    Google Scholar 

  52. Leon-Barua R, Recavarren-Arce S, Chinga-Alayo E, Rodriguez-Ulloa C, Taylor DN, Gotuzzo E, Kosek M, Eza D, Gilman RH. Helicobacter pylori-associated chronic atrophic gastritis involving the gastric body and severe disease by Vibrio cholerae. Trans R Soc Trop Med Hyg. 2006;100:567–72.

    Google Scholar 

  53. Shahinian ML, Passaro DJ, Swerdlow DL, Mintz ED, Rodriguez M, Parsonnel J. Helicobacter pylori and epidemic Vibrio cholerae O1 infection in Peru. Lancet. 2000;355:377–8.

    Google Scholar 

  54. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171:33–8.

    Google Scholar 

  55. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301:2120–8.

    Google Scholar 

  56. Turco R, Martinelli M, Miele E, Roscetto E, Del PM, Greco L, Staiano A. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther. 2010;31:754–9.

    Google Scholar 

  57. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr. 2007;44:41–4.

    Google Scholar 

  58. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117:e817–20.

    Google Scholar 

  59. Schnell S, Herman RA. Should digestion assays be used to estimate persistence of potential allergens in tests for safety of novel food proteins? Clin Mol Allergy. 2009;7:1.

    Google Scholar 

  60. Untersmayr E, Scholl I, Swoboda I, Beil WJ, Forster-Waldl E, Walter F, Riemer A, Kraml G, Kinaciyan T, Spitzauer S, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol. 2003;112:616–23.

    Google Scholar 

  61. Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol. 2008;121:1301–8.

    Google Scholar 

  62. Untersmayr E, Jensen-Jarolim E. The effect of gastric digestion on food allergy. Curr Opin Allergy Clin Immunol. 2006;6:214–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marta Tavares .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tavares, M., Dias, J.A. (2017). Long-Term Effects of Achlorhydria on the Stomach (Helicobacter pylori and PPI Therapy). In: Till, H., Thomson, M., Foker, J., Holcomb III, G., Khan, K. (eds) Esophageal and Gastric Disorders in Infancy and Childhood. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11202-7_121

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11202-7_121

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11201-0

  • Online ISBN: 978-3-642-11202-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics